139 related articles for article (PubMed ID: 14675099)
1. Safety of plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleeding.
Sadeghi S; Marder VJ; Stewart D; Kong M; Humphries J; Baumbach GA; Jesmok G
J Thromb Haemost; 2003 Dec; 1(12):2621-5. PubMed ID: 14675099
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models.
Vanderschueren S; Collen D
Thromb Haemost; 1996 May; 75(5):816-9. PubMed ID: 8725729
[TBL] [Abstract][Full Text] [Related]
3. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.
Stewart D; Kong M; Novokhatny V; Jesmok G; Marder VJ
Blood; 2003 Apr; 101(8):3002-7. PubMed ID: 12446443
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
5. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
Marder VJ; Comerota AJ; Shlansky-Goldberg RD; Davis JP; Deng C; Hanna K; Fineberg D
J Thromb Haemost; 2012 Jun; 10(6):985-91. PubMed ID: 22487025
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2-5.
Marder VJ; Manyak S; Gruber T; Goyal A; Moreno G; Hunt J; Bromirski J; Scuderi P; Petteway SR; Novokhatny V
Thromb Haemost; 2010 Oct; 104(4):780-7. PubMed ID: 20806125
[TBL] [Abstract][Full Text] [Related]
7. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
8. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
9. Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke.
Schmülling S; Rudolf J; Strotmann-Tack T; Grond M; Schneweis S; Sobesky J; Thiel A; Heiss WD
Cerebrovasc Dis; 2003; 16(3):183-90. PubMed ID: 12865603
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
[TBL] [Abstract][Full Text] [Related]
11. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.
Hsia J; Hamilton WP; Kleiman N; Roberts R; Chaitman BR; Ross AM
N Engl J Med; 1990 Nov; 323(21):1433-7. PubMed ID: 2122251
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model.
Montoney M; Gardell SJ; Marder VJ
Circulation; 1995 Mar; 91(5):1540-4. PubMed ID: 7867196
[TBL] [Abstract][Full Text] [Related]
13. Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin.
Garabedian HD; Gold HK; Leinbach RC; Svizzero TA; Finkelstein DM; Guerrero JL; Collen D
J Am Coll Cardiol; 1991 Apr; 17(5):1213-22. PubMed ID: 1706738
[TBL] [Abstract][Full Text] [Related]
14. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
[TBL] [Abstract][Full Text] [Related]
15. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
Giugliano RP; McCabe CH; Antman EM; Cannon CP; Van de Werf F; Wilcox RG; Braunwald E;
Am Heart J; 2001 May; 141(5):742-50. PubMed ID: 11320361
[TBL] [Abstract][Full Text] [Related]
16. Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits.
Clark WM; Madden KP; Lyden PD; Zivin JA
Stroke; 1991 Jul; 22(7):872-6. PubMed ID: 1906646
[TBL] [Abstract][Full Text] [Related]
17. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
Cohen M; Théroux P; Borzak S; Frey MJ; White HD; Van Mieghem W; Senatore F; Lis J; Mukherjee R; Harris K; Bigonzi F;
Am Heart J; 2002 Sep; 144(3):470-7. PubMed ID: 12228784
[TBL] [Abstract][Full Text] [Related]
18. Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.
Vaughan DE; Declerck PJ; De Mol M; Collen D
J Clin Invest; 1989 Aug; 84(2):586-91. PubMed ID: 2503540
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic activity of BB-10153, a thrombin-activatable plasminogen.
Comer MB; Cackett KS; Gladwell S; Wood LM; Dawson KM
J Thromb Haemost; 2005 Jan; 3(1):146-53. PubMed ID: 15634278
[TBL] [Abstract][Full Text] [Related]
20. Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy.
Aamir R; Fyffe C; Korin N; Lawrence DA; Su EJ; Kanapathipillai M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
